We serve Chemical Name:3-Bromo-4-fluorobenzoyl chloride CAS:672-75-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Bromo-4-fluorobenzoyl chloride
CAS.NO:672-75-3
Synonyms:3-bromo-4-fluoro-benzoic acid chloride;2613646;Benzoyl chloride, 3-bromo-4-fluoro-;3-Brom-4-fluor-benzoylchlorid;3-Bromo-4-fluoro-benzoyl chloride;GVR CF DE;MFCD04972690;3-Bromo-4-fluorobenzoyl chloride;3-Bromo-4-fluorobenzyl chloride;EINECS 211-596-9
Molecular Formula:C7H3BrClFO
Molecular Weight:237.454
HS Code:2916399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:241.9±25.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.562
PSA:17.07000
Exact Mass:235.903976
LogP:3.32
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3265
Packing Group:
Contact us for information like 3-bromo-4-fluoro-benzoic acid chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 211-596-9 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD04972690 Use and application,GVR CF DE technical grade,usp/ep/jp grade.
Related News: The vaccine significantly reduced — by 58% — the accumulation of neurofilament light chain in the blood. This is an important biomarker of neurodegenerative diseases, Novak said — damaged nerve cells release the substance, which leaks into the blood. 3-Bromo-4-fluorobenzoyl chloride manufacturer With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. 3-Bromo-4-fluorobenzoyl chloride supplier This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire. 3-Bromo-4-fluorobenzoyl chloride vendor With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. 3-Bromo-4-fluorobenzoyl chloride factory China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.
